News for hackers. Stuff that matters.
Re:How expensive do prescription drugs need to be to fund re... by rayiner on Wednesday March 27, 2019 @09:08AM (#19500436)
That’s an irrelevant distinction. The possibility of an acquisition is what fuels these biotech startups to invest in the first place. It doesn’t make a difference whether J&J is paying researchers or buying the startup that pays the researchers.

As to government funding, mentioned below, the 90/10 rule applies in pharma as much as anything. The last 10% is 90% of the work.

There are no comments on this comment yet.